Sage Therapeutics, Inc. (SAGE)
NASDAQ: SAGE · Real-Time Price · USD
6.56
+0.17 (2.74%)
May 15, 2025, 1:36 PM - Market open
Sage Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 45.22 | 81.02 | 70.99 | 162.7 | 294.23 | 1,661 | Upgrade
|
| Short-Term Investments | 378.63 | 423.4 | 682.19 | 1,110 | 1,448 | 438.47 | Upgrade
|
| Cash & Short-Term Investments | 423.85 | 504.42 | 753.18 | 1,272 | 1,742 | 2,100 | Upgrade
|
| Cash Growth | -40.89% | -33.03% | -40.81% | -26.96% | -17.02% | 108.21% | Upgrade
|
| Accounts Receivable | 10.73 | 9.53 | 84.41 | 15.16 | 19.61 | - | Upgrade
|
| Other Receivables | 2.7 | 3.4 | 4.2 | - | - | - | Upgrade
|
| Receivables | 13.43 | 12.93 | 88.61 | 15.16 | 19.61 | - | Upgrade
|
| Inventory | - | - | 1.5 | 1.7 | 1.4 | - | Upgrade
|
| Prepaid Expenses | 17.19 | 13.95 | 24.73 | 47.63 | 37.34 | 22.82 | Upgrade
|
| Restricted Cash | - | - | 1.33 | - | - | - | Upgrade
|
| Total Current Assets | 454.48 | 531.3 | 869.35 | 1,337 | 1,801 | 2,122 | Upgrade
|
| Property, Plant & Equipment | 11.14 | 11.64 | 6.38 | 13.43 | 19.13 | 31.82 | Upgrade
|
| Other Long-Term Assets | 4.06 | 4.28 | 6.55 | 6.04 | 5.52 | 5.06 | Upgrade
|
| Total Assets | 469.67 | 547.22 | 882.28 | 1,356 | 1,825 | 2,159 | Upgrade
|
| Accounts Payable | 5.44 | 12.7 | 10.32 | 18.95 | 10.45 | 3.69 | Upgrade
|
| Accrued Expenses | 35.75 | 42.29 | 56.68 | 72.67 | 67.28 | 54.85 | Upgrade
|
| Current Portion of Leases | 1.81 | 1.32 | 5.17 | 7.64 | 7.47 | 8.66 | Upgrade
|
| Other Current Liabilities | 6.78 | 15.31 | 10.59 | - | - | - | Upgrade
|
| Total Current Liabilities | 49.78 | 71.62 | 82.75 | 99.26 | 85.19 | 67.2 | Upgrade
|
| Long-Term Leases | 10.04 | 10.52 | - | 4.49 | 10.96 | 19.44 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0.1 | 0.1 | 0.27 | Upgrade
|
| Total Liabilities | 59.82 | 82.13 | 82.75 | 103.85 | 96.26 | 86.91 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 3,443 | 3,436 | 3,370 | 3,291 | 3,227 | 3,110 | Upgrade
|
| Retained Earnings | -3,033 | -2,970 | -2,570 | -2,028 | -1,495 | -1,037 | Upgrade
|
| Treasury Stock | -0.4 | -0.4 | -0.4 | -0.4 | -0.4 | -0.4 | Upgrade
|
| Comprehensive Income & Other | 0.14 | 0.24 | -0.81 | -10.21 | -2.66 | 0.42 | Upgrade
|
| Shareholders' Equity | 409.85 | 465.09 | 799.53 | 1,253 | 1,729 | 2,072 | Upgrade
|
| Total Liabilities & Equity | 469.67 | 547.22 | 882.28 | 1,356 | 1,825 | 2,159 | Upgrade
|
| Total Debt | 11.86 | 11.84 | 5.17 | 12.13 | 18.43 | 28.1 | Upgrade
|
| Net Cash (Debt) | 412 | 492.58 | 748.02 | 1,260 | 1,724 | 2,071 | Upgrade
|
| Net Cash Growth | -42.27% | -34.15% | -40.65% | -26.89% | -16.78% | 113.26% | Upgrade
|
| Net Cash Per Share | 6.73 | 8.11 | 12.50 | 21.25 | 29.38 | 39.08 | Upgrade
|
| Filing Date Shares Outstanding | 62.62 | 61.48 | 60.11 | 59.72 | 59.05 | 58.38 | Upgrade
|
| Total Common Shares Outstanding | 62.54 | 61.36 | 60.04 | 59.51 | 58.94 | 58.31 | Upgrade
|
| Working Capital | 404.7 | 459.69 | 786.6 | 1,238 | 1,715 | 2,055 | Upgrade
|
| Book Value Per Share | 6.55 | 7.58 | 13.32 | 21.05 | 29.34 | 35.54 | Upgrade
|
| Tangible Book Value | 409.85 | 465.09 | 799.53 | 1,253 | 1,729 | 2,072 | Upgrade
|
| Tangible Book Value Per Share | 6.55 | 7.58 | 13.32 | 21.05 | 29.34 | 35.54 | Upgrade
|
| Machinery | - | 1.67 | 3.9 | 3.49 | 2.6 | 4.62 | Upgrade
|
| Leasehold Improvements | - | - | 5.51 | 5.51 | 5.39 | 9.22 | Upgrade
|
Updated Apr 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.